Surgical management of intraabdominal metastases from melanoma: Role of the neutrophil to lymphocyte ratio as a potential prognostic factor

World Journal of Surgery

Volumn 38, Issue 6, 2014, Pages 1542-1550

  Cananzi, Ferdinando C M ^a   Dalgleish, Angus ^b   Mudan, Satvinder ^a  

^a Department of Surgery Royal Marsden ^*  (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ABDOMINAL NEOPLASMS; ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FACTUAL DATABASE; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMAN; LYMPHOCYTE COUNT; MALE; MELANOMA; METABOLISM; MIDDLE AGED; MORTALITY; NEUTROPHIL; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; SECONDARY; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COHORT STUDIES; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHOCYTE COUNT; MALE; MELANOMA; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84902189451     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2418-6     Document Type: Article

References (38)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29
2. Siegel R, DeSantis C, Virgo K et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220-241
3. Balch CM, Gershenwald JE, Soong SJ et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-6206
4. Allen PJ, Coit DG (2002) The role of surgery for patients with metastatic melanoma. Curr Opin Oncol 14:221-226
5. Morton DL, Mozzillo N, Thompson JF et al (2007) An international, randomized, phase III trial of bacillus Calmette-Guerin (BCG) plus allogeneic melanoma vaccine (MCV) or placebo after complete resection of melanoma metastatic to regional or distant sites. J Clin Oncol 25:8508
6. Sanki A, Scolyer RA, Thompson JF (2009) Surgery for melanoma metastases of the gastrointestinal tract: indications and results. Eur J Surg Oncol 35:313-319
7. Wasif N, Bagaria SP, Ray P et al (2011) Does metastasectomy improve survival in patients with stage IV melanoma? A cancer registry analysis of outcomes. J Surg Oncol 104:111-115
8. Ollila DW, Gleisner AL, Hsueh EC (2011) Rationale for complete metastasectomy in patients with stage IV metastatic melanoma. J Surg Oncol 104:420-424
9. Walsh SR, Cook EJ, Goulder F et al (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181-184
10. Yamanaka T, Matsumoto S, Teramukai S et al (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215-220
11. Liu H, Tabuchi T, Takemura A et al (2008) The granulocyte/lymphocyte ratio as an independent predictor of tumour growth, metastasis and progression: its clinical applications. Mol Med Rep 1:699-704
12. Kishi Y, Kopetz S, Chun YS et al (2009) Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16:614-622
13. Wang S, Zhang Z, Fang F et al (2011) The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett 2:735-740
14. Kim YH, Choi WJ (2012) The effectiveness of postoperative neutrophils to lymphocytes ratio in predicting long-term recurrence after stomach cancer surgery. J Korean Surg Soc 83:352-359
15. Dindo D, Dermartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213
16. Gomez D, Farid S, Malik HZ et al (2008) Preoperative neutrophil-to- lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32:1757-1762
17. Chua W, Charles KA, Baracos VE et al (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104:1288-1295
18. Garcea G, Ladwa N, Neal CP et al (2011) Preoperative neutrophil-to- lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg 35:868-872
19. Sharaiha RZ, Halazun KJ, Mirza F et al (2011) Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 18:3362-3369
20. Mallappa S, Sinha A, Gupta S et al (2012) Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis 15:323-328
21. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9:239-252
22. O'Byrne KJ, Dalgleish AG (2001) Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85:473-483
23. Balkwill F, Mantovani A (2010) Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther 87:401-406
24. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883-899
25. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674
26. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436-444
27. Sarraf KM, Belcher E, Raevsky E et al (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137:4258
28. Halazun KJ, Hardy MA, Rana AA et al (2009) Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 250:141-151
29. Aliustaoglu M, Bilici A, Seker M et al (2010) The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer. Hepatogastroenterology 57:640-645
30. Liu H, Liu G, Bao Q et al (2010) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma. J Gastrointest Cancer 41:116-120
31. Azab B, Bhatt VR, Phookan J et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19:217-224
32. Perez DR, Baser RE, Cavnar MJ et al (2012) Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol 20:593-599
33. Galon J, Franck P, Marincola FM et al (2012) Cancer classification using the Immunoscore: a worldwide task force. J Transl Med 10:205
34. Dunn GP, Old LJ, Schreiber RD (2004) The three Es of cancer immunoediting. Annu Rev Immunol 22:329-360
35. Vesely MD, Kershaw MH, Schreiber RD et al (2011) Natural innate and adaptive immunity to cancer. Annu Rev Immunol 29:235-271
36. Almand B, Resser J, Lindman B et al (2000) Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6:1755-1766
37. Salvadori S, Martinelli G, Zier K (2000) Resection of solid tumors reverses T cell defects and restores protective immunity. J Immunol 164:2214-2220
38. Evans C, Galustian C, Kumar D et al (2009) Impact of surgery on immunologic function: comparison between minimally invasive techniques and conventional laparotomy for surgical resection of colorectal tumors. Am J Surg 197:238-245